Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada's health framework law holds key provisions for device companies

This article was originally published in Clinica

Executive Summary

Transparency, balancing risks and benefits and managing the regulation of innovative products: these are the main cornerstones of Canada's proposed new framework healthcare law. All three are also aspects that are driving medical device regulatory policy discussions in the EU, and the Canadian document is useful in terms of understanding developing regulatory trends which are increasingly putting patients and risks associated with healthcare services and products at the centre of decision-making.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel